Homeostatic signaling systems stabilize neural function through the modulation of neurotransmitter receptor abundance, ion channel density, and presynaptic neurotransmitter release. Molecular mechanisms that drive these changes are being unveiled. In theory, molecular mechanisms may also exist to oppose the induction or expression of homeostatic plasticity, but these mechanisms have yet to be explored. In an ongoing electrophysiologybased genetic screen, we have tested 162 new mutations for genes involved in homeostatic signaling at the Drosophila NMJ. This screen identified a mutation in the rab3-GAP gene. We show that Rab3-GAP is necessary for the induction and expression of synaptic homeostasis. We then provide evidence that Rab3-GAP relieves an opposing influence on homeostasis that is catalyzed by Rab3 and which is independent of any change in NMJ anatomy. These data define roles for Rab3-GAP and Rab3 in synaptic homeostasis and uncover a mechanism, acting at a late stage of vesicle release, that opposes the progression of homeostatic plasticity.
INTRODUCTION
Throughout the nervous system there is evidence that homeostatic signaling systems can modulate synaptic transmission or neuronal excitability and thereby stabilize neural function (Davis, 2006; Marder and Goaillard, 2006; Turrigiano, 2008) . It is now widely hypothesized that defective homeostatic signaling may contribute to the cause or progression of diverse neurological disease. Maladaptive homeostatic signaling may participate in the progression of Alzheimer's disease (Kamenetz et al., 2003) and posttraumatic epilepsy (Houweling et al., 2005) , while impaired homeostatic signaling could reasonably contribute to other forms of epilepsy (Davis, 2006, for review) and complex neurological disease (Dickman and Davis, 2009) . Ultimately, however, the involvement of homeostatic signaling in neural development and disease will require a molecular description of this form of neural plasticity.
A number of recent studies have identified molecules that when disrupted or deleted block the homeostatic control of neural function. For example, the secreted signaling molecules BDNF and TNF-alpha have both been shown to be necessary for a homeostatic increase in glutamate receptor abundance following prolonged activity blockade (Rutherford et al., 1997; Stellwagen and Malenka, 2006) . Likewise, mechanisms that participate in the translation, trafficking or scaffolding of glutamate receptors have been shown to be required (Sutton and Schuman, 2006; Seeburg et al., 2008) . At the Drosophila neuromuscular junction, a presynaptic signaling system that includes the Eph receptor, Ephexin, Cdc42, and presynaptic calcium channels has been implicated in the homeostatic control presynaptic neurotransmitter release (Frank et al., 2006; Frank et al., 2009) . These are among a growing list of studies that have identified molecules that are necessary for the induction or execution of homeostatic signaling in the nervous system (Futai et al., 2007; Dickman and Davis, 2009) .
To date, every molecule that has been identified normally functions to promote homeostatic change. In theory, homeostatic signaling systems will also require mechanisms that limit or oppose homeostatic compensation (Davis, 2006) . However, in the nervous system, molecular mechanisms that limit or oppose homeostatic plasticity remain entirely unknown. In an ongoing, electrophysiology-based, forward genetic screen, we have uncovered a presynaptic signaling system that participates in synaptic homeostasis and includes a mechanism to oppose the homeostatic increase of presynaptic neurotransmitter release.
At the NMJ of organisms ranging from Drosophila to human, decreased postsynaptic neurotransmitter receptor sensitivity elicits a homeostatic, compensatory increase in presynaptic transmitter release that precisely offsets the decrease in postsynaptic receptor function and thereby restores normal muscle depolarization (Davis, 2006) . We previously reported a genetic screen, based upon synaptic electrophysiology at the Drosophila NMJ, designed to identify mutations that disrupt the homeostatic control of presynaptic release (Dickman and Davis, 2009 ). Here, we report a continuation of this screen and identify the Rab3 GTPase-activating protein (Rab3-GAP) as an essential component involved in this homeostatic signaling system. Rab3 and Rab3-GAP have been implicated in the modulation of presynaptic neurotransmitter release (Sü dhof, 2004; Sakane et al., 2006) . Rab3 is a small GTPase that is present in relatively high copy number on synaptic vesicles (Takamori et al., 2006) . Only the GTP-bound form of Rab3 associates with the membrane of synaptic vesicles (Fischer von Mollard et al., 1990) . In mammals, the investigation of Rab3 function is complicated by the presence of four Rab3 paralogs (Rab3A-D), which are functionally redundant in mice (Schlü ter et al., 2004) . Based on the finding that overexpression of either Rab3A-D or a constitutively active Rab3A decrease Ca 2+ -triggered exocytosis (Holz et al., 1994; Johannes et al., 1994; Chung et al., 1999; Iezzi et al., 1999; Schlü ter et al., 2002) , and that rab3A knockout mice release more transmitter quanta in response to stimulation (Geppert et al., 1997) , it was initially suggested that Rab3 directly or indirectly inhibits secretion (Schlü ter et al., 2002) . However, the generation of quadruple rab3A-D knockout mice uncovered a 30% decrease in synaptic vesicular release probability indicating that Rab3 might function, instead, to promote presynaptic release (Schlü ter et al., 2004 (Schlü ter et al., , 2006 . The examination of Rab3 function is greatly facilitated in Drosophila because there is only one predicted rab3 gene in fruit flies (Lloyd et al., 2000) . At the Drosophila NMJ, Rab3 has been recently shown to be crucial for the organization of presynaptic active zone proteins including calcium channels (Graf et al., 2009 ). Rab3-GAP is predicted to regulate the function of Rab3 by accelerating the hydrolysis of GTP-bound Rab3 to GDP-bound Rab3 (Fukui et al., 1997) . Mutations in rab3-GAP cause Warburg Micro syndrome, an autosomal recessive disorder causing severe mental retardation (Aligianis et al., 2005) . However, very little is known about the relevance of Rab3-GAP function during synaptic transmission. The only study that has investigated Rab3-GAP function in the context of synaptic transmission found altered short-term plasticity at hippocampal CA1 synapses of rab3-GAP mutant mice (Sakane et al., 2006) . Here, we define a role for Rab3-GAP and Rab3 during the homeostatic modulation of synaptic transmission and describe a form of negative regulation that acts to oppose the progression of synaptic homeostasis at a late stage of synaptic vesicle release.
RESULTS
An Electrophysiology-Based Forward Genetic Screen Identifies rab3-GAP A rapid, homeostatic increase in presynaptic transmitter release can be observed at the Drosophila NMJ within 10 min following bath application of the glutamate receptor antagonist philanthotoxin-433 (PhTX; Frank et al., 2006) . Previously, this assay was used as the basis for a forward genetic screen to isolate mutations that disrupt the rapid induction of synaptic homeostasis (Dickman and Davis, 2009) . We have continued this screening strategy, testing the involvement of an additional 162 independent mutations. In brief, we generated a list of 450 genes that had been previously annotated as having enriched expression in the nervous system. From this list, we obtained mutations in 162 independent genes from the gene disruption project (the FlyBase Consortium), whenever possible selecting transposon insertions that reside within gene coding regions. For each of these 162 mutant lines, we recorded the amplitudes of spontaneous miniature EPSPs (mEPSPs) and action potential-evoked EPSPs following incubation of the NMJ in PhTX (10 mM) for 10 min (n R 4 NMJs per mutant, muscles 6 and 7, segment 2/3) (Figure 1 ). We then assessed baseline synaptic transmission (EPSP and mEPSP in the absence of PhTX) in 73 mutant lines (n R 4 NMJs per mutant). As shown in Figure 1B , the mean mEPSP amplitude after PhTX incubation, averaging across all mutants tested, was 0.62 ± 0.14 mV (n = 162). This value is similar to the mean mEPSP amplitude seen in wild-type animals following PhTX incubation (0.62 ± 0.04 mV; n = 10; Figure 1B , black circle; p = 0.98) and is significantly smaller than the mean mEPSP amplitude recorded at wild-type NMJs in the absence PhTX (0.97 ± 0.06 mV; n = 12; Figure 1B , open circle; p < 0.001). The mean EPSP amplitude after PhTX application was similar comparing mutant synapses (32.2 ± 6.5 mV; N = 162) and wild-type synapses (36.5 ± 1.2 mV; n = 10; Figure 1C , open circle; p = 0.04). Thus, the majority of the mutant lines that we tested showed robust synaptic homeostasis, restoring EPSP amplitudes toward wildtype levels despite a large reduction in mEPSP amplitude in the presence of PhTX. However, ten independent mutant lines had average EPSP amplitudes that were more than two standard deviations smaller than the distribution mean ( Figure 1C , red bars; Figure 1D , red circles). These represent candidate mutations that may disrupt synaptic homeostasis.
Next, we explored the basis for the apparent block of synaptic homeostasis in these ten candidate homeostasis mutants. We assayed synaptic transmission in the absence of PhTX for each of these ten mutations to ensure that the mutations did not simply disrupt neurotransmission. We uncovered defects in baseline transmission in four out of the ten candidate homeostasis mutants (data not shown), leaving us with six mutant lines (3.7%) that have a specific block in the rapid induction of synaptic homeostasis ( Figure 1A ). Next, we sought to determine if there might have been false negatives in our screen. For example, if a mutation had increased baseline synaptic transmission relative to wild-type, failed homeostatic compensation following PhTX application would cause EPSP amplitudes to be reduced, but the reduction might result in an EPSP similar to that observed in wild-type. To assess this possibility, we assayed synaptic transmission in the absence of PhTX for 73 of the mutations, allowing us to compare each mutation with and without PhTX. We did not uncover any additional candidate homeostasis mutants, indicating that our false negative rate is quite low. These analyses also highlight the specificity of those mutations that we did identify as candidate homeostatic mutants. Of the six mutations that did show a strong block of synaptic homeostasis ( Figure 1D , red circles) one is a transposon insertion that resides in the Drosophila homolog of rab3-GAP (CG7061; Figures 1D and 1E , filled red circle). This gene was selected for further analysis.
The Rapid Induction of Synaptic Homeostasis Is Blocked in rab3-GAP Mutants The rab3-GAP mutation identified in our screen is a transposon insertion residing within an untranslated 5 0 exon (pBac c04953 , henceforth called rab3-GAP; Figure 1E ). We find a significant 87% ± 1% (n = 6 samples) decrease in mRNA levels in rab3-GAP compared to wild-type, indicating that the rab3-GAP transposon insertion is a loss-of-function allele (not shown). We then examined baseline synaptic transmission in rab3-GAP and find that the average mEPSP amplitude, EPSP amplitude, and quantal content do not differ from wild-type (mEPSP, p = 0.4; EPSP, p = 0.98; quantal content, p = 0.18; Figure 2 ). Throughout this study, average values are presented in figure format and sample sizes are reported in figure legends. For each data set, average values with associated sample sizes are also presented in Table  S1 , available online. Thus, we conclude that there is no major defect in baseline synaptic transmission in a rab3-GAP loss-offunction allele.
Next, we confirmed that rab3-GAP mutations disrupt the rapid induction of synaptic homeostasis. Bath application of 10 mM PhTX induced a significant decrease in mEPSP amplitude at both wild-type synapses ( Figure 2D ; p < 0.001) and rab3-GAP mutant synapses ( Figure 2D ; p < 0.001). Note that in all experiments p values are based on the comparison of data collected for a single genotype in the presence versus absence of PhTX. At wild-type synapses, a significant increase in quantal content ( Figure 2F ; p < 0.001) offsets the decrease in postsynaptic mEPSP amplitude and restores EPSP amplitudes to baseline values. By contrast, in the rab3-GAP mutants, there is no homeostatic increase in quantal content following application of PhTX to the NMJ ( Figure 2F ; p = 0.85). As a consequence, EPSP amplitudes are significantly smaller in the rab3-GAP mutant following PhTX application compared to rab3-GAP mutants recorded in the absence of PhTX ( Figure 2E ; p < 0.001). A similar block of synaptic homeostasis was also observed when rab3-GAP was placed in trans to a deficiency [Df(2L)ED775] that uncovers the rab3-GAP locus ( Figure 1E ). There is no apparent defect in baseline synaptic transmission in rab3-GAP/Df mutant animals ( Figures 2D-2F ). However, following PhTX application, the average mEPSP amplitude (p < 0.001) and average EPSP amplitude (p < 0.001) are significantly decreased in rab3-GAP/Df mutants and quantal content remains unchanged ( Figure 3F ). These data confirm that the rapid induction of synaptic homeostasis is blocked in rab3-GAP mutants, and confirm that the rab3-GAP transposon insertion mutation is likely to be loss-offunction mutation in the rab3-GAP gene. It is worth emphasizing that the defect in synaptic homeostasis is not accompanied by a deficit in baseline synaptic transmission under standard recording conditions.
Rab3-GAP Functions Presynaptically during the Induction of Synaptic Homeostasis
The rab3-GAP gene is ubiquitously expressed in both rats (Oishi et al., 1998) and Drosophila (Chintapalli et al., 2007) and is enriched in the synaptic, soluble fraction of rat brains (Oishi et al., 1998) . Therefore, we hypothesize that Rab3-GAP acts presynaptically during synaptic homeostasis. To test this possibility, we generated a UAS-CFP-rab3-GAP transgene (CFP was placed at the N terminus of rab3-GAP cDNA; see Experimental Procedures) and expressed this transgene in the rab3-GAP mutant background using the pan-neuronal GAL4 driver line elav-GAL4. As shown in Figures 2C and 2F , a homeostatic increase in presynaptic quantal content (p < 0.001) is observed following application of PhTX to the rab3-GAP mutant expressing the UAS-CFP-rab3-GAP transgene. The observed increase in quantal content offsets the PhTX-dependent decrease in mEPSP amplitude (p < 0.001; Figure 2D ) and restores EPSP amplitudes to baseline values (p = 0.28, comparing EPSP amplitude with and without PhTX; Figure 2E ). Thus, presynaptic expression of UAS-CFP-rab3-GAP rescues synaptic homeostasis in the rab3-GAP mutant background. These data support the conclusion that presynaptic rab3-GAP is sufficient for the rapid induction of synaptic homeostasis.
It should be noted that the input resistance of rab3-GAP mutant muscles is significantly smaller than that observed in wild-type muscles ( Figure 2G , red bars). However, the defect in input resistance persists in the rab3-GAP rescue animals even though synaptic homeostasis is fully restored. Thus, this effect , and a rab3-GAP mutant NMJ in which UAS-CFP-rab3-GAP was driven using the panneuronal driver elav-GAL4 (C, ''neural rescue'').
(D-G) Average mEPSP amplitude (D), EPSP amplitude (E), quantal content (calculated as EPSP amplitude/mEPSP amplitude, F), and muscle input resistance (R in , G). The following genotypes are presented: wild-type synapses (ÀPhTX, n = 12; +PhTX, n = 8; white/gray bars), rab3-GAP mutant NMJs (ÀPhTX, n = 16; +PhTX, n = 16; red bars), rab3-GAP/Df synapses (ÀPhTX, n = 9; +PhTX, n = 13; red bars), and rab3-GAP mutant NMJs bearing a UAS-CFPrab3-GAP rescue construct driven by elav-Gal4 (ÀPhTX, n = 8; +PhTX, n = 21; blue bars). PhTX challenge (À/+PhTX) are shown as open and filled bars, respectively. The defect in homeostatic compensation was rescued by driving UAS-CFP-rab3-GAP using elav-GAL4 (blue bars, F).
(H) Image of an in vivo Drosophila NMJ (muscle 4, segment A2) in which UAS-CFP-rab3-GAP was overexpressed using the panneuronal driver elav-Gal4. The right image shows the bouton highlighted by the white box in the left image. Note that Rab3-GAP-CFP forms discrete puncta that are distributed throughout the presynaptic nerve terminal and the axon.
(I) Immunostaining against the active zone component Bruchpilot (anti-nc82, ''nc82,'' green, left) and UAS-CFPrab3-GAP (anti-GFP, ''CFP-rab3-GAP,'' red, middle) of a fixed NMJ (muscle 4, segment A2) in which UAS-CFPrab3-GAP was expressed using elav-Gal4. All scale bars are 5 mm.
Error bars represent SEM. See also Figure S1 .
cannot be the cause of impaired synaptic homeostasis in the rab3-GAP mutant. The cause of impaired muscle input resistance could represent a genetically separable postsynaptic function of rab3-GAP. We also controlled for the possibility that overexpression of Rab3-GAP levels might influence baseline synaptic transmission and synaptic homeostasis. Therefore, we overexpressed UAS-CFP-rab3-GAP in a wild-type background and found no difference in synaptic homeostasis with respect to control ( Figure S1 ) and a slight, statistically significant, decrease in evoked neurotransmitter release (p = 0.04; Figure S1 ). Thus, elevated Rab3-GAP levels do not cause an increase in neurotransmitter release during baseline conditions or after a homeostatic challenge.
To investigate where Rab3-GAP localizes within the presynaptic neuron, we imaged CFP-Rab3-GAP in larvae expressing UAS-CFP-rab3-GAP under the control of the elav-GAL4 driver. Ectopically expressed CFP-Rab3-GAP forms small puncta that are distributed throughout the axon and presynaptic nerve terminal in vivo ( Figure 2H ). Within individual synaptic boutons, CFP-Rab3-GAP appears to concentrate at or near the presynaptic plasma membrane. We also show that UAS-CFP-rab3-GAP resides in close proximity to active zones by colabeling with the active zone marker Brp ( Figure 1I ). Since the UAS-CFP-rab3-GAP transgene is sufficient to rescue synaptic homeostasis, we propose that this distribution reflects, at least in part, the sites at which Rab3-GAP normally functions within the presynaptic nerve terminal, where it could participate in the modulation of transmitter release during synaptic homeostasis ( Figure 2H ).
Rab3-GAP Is Required for the Sustained Expression of Synaptic Homeostasis
We next asked whether Rab3-GAP is also required for the sustained expression of synaptic homeostasis. To do so, we generated double-mutant flies harboring mutations in both rab3-GAP and GluRIIA, a subunit of the muscle-specific ionotropic glutamate receptors present at the Drosophila NMJ (Petersen et al., 1997) . As shown previously, the GluRIIA SP16 mutation causes a significant decrease in mEPSP amplitude compared to wildtype ( Figures 3A, 3C , and 3E; p < 0.001) (Petersen et al., 1997; Frank et al., 2006 Frank et al., , 2009 . This decrease in mEPSP amplitude is offset by a pronounced increase in quantal content ( Figure 3G , white and gray bar; p < 0.001) that restores EPSP amplitudes to wild-type values ( Figures 3A, 3C , and 3F, white and gray bar; p = 0.8). Because this perturbation persists throughout larval development, this effect has been interpreted as the persistent expression of synaptic homeostasis (Frank et al., 2006) .
We then examined GluRIIA SP16 , rab3-GAP double mutants. In these double mutants, the mEPSP amplitudes are significantly reduced compared to rab3-GAP mutant synapses alone (Figures 3B, 3D, and 3E; p < 0.001). However, there is no significant change in presynaptic quantal content at GluRIIA SP16 , rab3-GAP double-mutant synapses ( Figure 3G , filled red bar) compared to rab3-GAP control synapses ( Figure 3G , red open bar; p = 0.2). As a consequence, the mean EPSP amplitude of GluRIIA SP16 , rab3-GAP double-mutant NMJs ( Figure 3F ) is significantly smaller than the EPSP amplitude recorded in rab3-GAP mutants alone ( Figures 3B, 3D , and 3F; p < 0.001). Based upon these data, we conclude that the rab3-GAP mutation blocks synaptic homeostasis in the GluRIIA mutant background. By extension, we conclude that rab3-GAP is necessary for both the rapid induction and the sustained expression of synaptic homeostasis at the Drosophila NMJ.
Synaptic Morphology Is Normal in rab3-GAP Mutants
In principle, the defect in synaptic homeostasis seen in rab3-GAP animals could be due to altered synapse development. This is a particular concern given the recent demonstration that rab3 mutations cause a dramatic change in synaptic development at the Drosophila NMJ (Graf et al., 2009) . However, the absolute number of active zones per NMJ as assayed by immunostaining against the active zone component Bruchpilot (Brp) in rab3-GAP (321 ± 68, n = 6; Figure 4E , left) is not significantly different when compared to wild-type (267 ± 24, n = 6, p = 0.47). We also quantified the density of active zones per NMJ area by normalizing the number of Brp puncta to synapse area, which was assessed by costaining with an antibody recognizing the postsynaptic protein Discs-large (Dlg; Figures 4A and 4B , red). We found no apparent difference in active zone density comparing the rab3-GAP mutant (1.89 ± 0.17, n = 9; Figure 4E , right) with wild-type NMJs (1.81 ± 0.13, n = 7, p = 0.7). We next probed the absolute number of boutons per NMJ at muscle 6/7. We find that bouton number did not differ between rab3-GAP (78 ± 5, n = 9; Figures 4D and 4F ) and wild-type (74 ± 9, n = 7; Figures 4C and 4F; p = 0.71). We also asked whether there was a change in the abundance of the synaptic vesicle protein Synaptotagmin 1 (anti-Syt). We did not detect a significant difference in anti-Syt intensity between rab3-GAP (745 ± 16 a.u., (E-H) Average mEPSP amplitude (E), EPSP amplitude (F), quantal content (G), and muscle input resistance (R in , H) from wild-type (n = 7; white bars), GluRIIA SP16 mutants (n = 11; gray bars), rab3-GAP mutants (n = 6; bars outlined in red), rab3-GAP, GluRIIA SP16 double mutants (n = 15; red bars).
The decrease in mEPSP amplitude induced a significant (p < 0.001) increase in quantal content in GluRIIA SP16 mutants (gray bar, G) relative to wild-type (white bar, G). In contrast, there was no significant increase in quantal content in rab3-GAP, GluRIIA SP16 double mutants (p = 0.2; red bar, G) relative to rab3-GAP mutants (bar outlined in red, G), indicating that the sustained expression of synaptic homeostasis is blocked in the rab3-GAP, GluRIIA SP16 double mutants. Error bars represent SEM. n = 9; Figure 4G ) and wild-type (803 ± 29 a.u., n = 9; p = 0.06). Finally, there was also no apparent change in the level and the distribution of Rab3 based on immunostaining against Rab3 ( Figure S2 ). Thus, the disruption of synaptic homeostasis is unlikely to be a secondary consequence of impaired anatomical development, active zone number, or a change in level or distribution of Rab3 at the NMJ. This is in agreement with our finding that Rab3-GAP mutations show normal baseline synaptic transmission.
Evidence for Altered Neurotransmitter Release at rab3-GAP Mutant Synapses
We have established that baseline synaptic transmission in response to a single action potential, under standard recording conditions, is unaltered in rab3-GAP mutants (Figures 2 and 3 ). Synaptic homeostasis is achieved by an increase in transmitter release probability in response to a single action potential in the same standard recording conditions. Somehow, the mutation in rab3-GAP prevents this homeostatic increase in release probability. To identify a function for Rab3-GAP that might be related to the homeostatic modulation of release probability, we tested baseline synaptic transmission under a variety of different stimulation protocols and extracellular calcium concentrations. As exemplified in Figures 5A and 5B, a 20 Hz stimulus train induced synaptic depression in both wild-type ( Figure 5A ) and rab3-GAP mutants ( Figure 5B ). Interestingly, the average steady-state EPSP amplitude was slightly, but statistically significantly larger at rab3-GAP synapses as compared to wild-type ( Figure 4C ; p < 0.001). As reported earlier (Figures 2 and 3) , there was no significant difference in the EPSP amplitude elicited by the first stimulus of a train between rab3-GAP mutants and wild-type ( Figure 5C ; p = 0.72). This shows that rab3-GAP mutant synapses exhibit less synaptic depression. Interestingly, these data are consistent with what has been observed at central synapses in rab3-GAP knockout mice (Sakane et al., 2006) .
We can conclude that the defect in synaptic homeostasis is not secondary to a defect in the recycling of the releasable pool of synaptic vesicles. We next assayed synaptic transmission at a range of different extracellular calcium concentrations [Ca 2+ ] e ( Figure 5D ). When quantal content in rab3-GAP (red) and wild-type (black) are plotted as a function of [Ca 2+ ] e ( Figure 5D ), we find a defect in synaptic transmission that is revealed primarily at lower extracellular calcium concentrations. Figure 5D ).
To further explore the defect in synaptic transmission that was uncovered at low [Ca 2+ ] e , we tested short-term plasticity at low [Ca 2+ ] e by stimulating the presynaptic axon repetitively at various interstimulus intervals (0.2 mM [Ca 2+ ] e ). Figure 5E shows a representative response from rab3-GAP (red trace) and wild-type (black trace) during the first six stimuli of a 20 Hz train at low [Ca 2+ ] e . Average paired-pulse ratios, calculated as the ratio between the first two EPSP amplitudes (EPSP2/EPSP1) of each stimulus train, are plotted for a range of interstimulus intervals ( Figure 5F ). At the shortest interstimulus interval tested (25 ms), the average paired-pulse ratio seen in rab3-GAP facilitated (1.5 ± 0.2; n = 9; Figure 5F , red data), while wild-type synapses showed depression (0.73 ± 0.03; Figure 5F , n = 7, black data, p = 0.005). With increasing interstimulus interval the paired-pulse facilitation seen in rab3-GAP decayed exponentially with a time constant of 24 ms ( Figure 5F , red exponential fit) reaching the paired-pulse ratio of wild-type at an interval of 100 ms. It is generally observed that the paired-pulse ratio is inversely related to transmitter release probability. Thus, our results indicate that there is a decrease in presynaptic release probability at rab3-GAP mutant synapses that is revealed at low extracellular calcium concentrations. Our results are, again, (E) Average number of nc82 (Brp) puncta per NMJ (left), and per synapse area (right) in wild-type (black bars, n = 7), and rab3-GAP mutant NMJs (red bars, n = 9) at muscle 4. There is no significant difference in active zone number (p = 0.47), or active zone density (p = 0.7). (F) Average number of boutons in wild-type (black bars, n = 7), and rab3-GAP NMJs (red bars; n = 9) at muscles 6/7 in abdominal segment 2. There is no significant difference in bouton number (p = 0.7). (G) Average intensity of synaptotagmin immunostaining (aSyt) in wild-type (black bars, n = 9), and rab3-GAP (red bars, n = 9) at muscle 4. There is no difference in antiSyt intensity (p = 0.06). Error bars represent SEM. See also Figure S2 . similar to what has been observed at CA1 synapses of rab3-GAP mouse mutants, which show an increase in paired-pulse facilitation (Sakane et al., 2006) .
Finally, we observe that the difference in EPSP amplitude between rab3-GAP and wild-type becomes less pronounced during the course of a 20 Hz stimulus train at low [Ca 2+ ] e ( Figures   5E and 5G ). On average, the EPSP amplitude of rab3-GAP mutants, which is significantly smaller in response to the first few stimuli, reaches the level of wild-type EPSPs after approximately the first 20-25 stimuli of a 20 Hz train ( Figure 5G ). In contrast, rab3-GAP mutant EPSPs remain significantly smaller than the amplitude of wild-type EPSPs if the stimulation frequency is reduced to 10 Hz ( Figure 5H ). Therefore, the initial small EPSP amplitude of rab3-GAP mutants at low [Ca 2+ ] e can reach wild-type levels if the mutant synapses are stimulated at a high frequency (20 Hz). Based on the decay of the presynaptic AP-evoked spatially averaged Ca 2+ transient at the Drosophila NMJ (tau $100 ms; Lnenicka et al., 2006) , this might indicate that the rab3-GAP mutants are capable of sustaining high levels of synaptic vesicle release if intraterminal Ca 2+ levels rise during a stimulus train.
At one level, the changes in baseline transmission that we detect in rab3-GAP are not dramatic. We observe changes in short-term plasticity, but the NMJ can sustain release during a 20 Hz train. Thus, the loss of synaptic homeostasis in the rab3-GAP mutant is unlikely to be due to a major defect in the release mechanism. However, the types of changes that we observe may inform us regarding rab3-GAP activity during homeostatic plasticity. For example, we find a defect in release probability that is revealed only at low extracellular calcium concentrations, and this effect is masked during a stimulus train when intracellular calcium concentrations increase. We speculate that this defect in release probability is directly related to impaired homeostatic modulation of presynaptic release probability. One possibility is that the activity of Rab3-GAP is necessary to position vesicles close to the presynaptic calcium channels. It is possible that this action is required for any subsequent homeostatic modulation of release probability (see Discussion). Irrespective of the exact mechanisms by which Rab3-GAP is regulating synaptic transmission, we have shown that Rab3-GAP is required for homeostatic plasticity at the Drosophila NMJ (Figures 2 and 3) . The role of Rab3-GAP in synaptic transmission has remained largely elusive, and the effects of rab3-GAP mutations on baseline synaptic transmission are relatively subtle in both mice (Sakane et al., 2006) and Drosophila (this study). Thus, we now define a new role for Rab3-GAP in the homeostatic modulation of vesicle release.
Synaptic Homeostasis Is Normal in rab3 Mutants
Drosophila Rab3-GAP is predicted to regulate the function of the small GTPase Rab3 (Lloyd et al., 2000) . Assuming that Rab3-GAP acts on Rab3, we considered two major possibilities for how Rab3-GAP might regulate synaptic homeostasis. First, Rab3-GAP-dependent hydrolysis of Rab3-GTP might be a required catalytic step for synaptic homeostasis. If this hypothesis is true, then Rab3 should also be required for synaptic homeostasis. A second possibility is that Rab3-GAP normally relieves an opposing effect of Rab3-GTP on homeostasis by inactivating Rab3. In this case, Rab3 would be a negative regulator of homeostasis, and mutations in rab3 might not disrupt synaptic homeostasis. To this point, our morphological data and our electrophysiological data favor the latter possibility. First, loss of rab3-GAP does not lead to a change in synapse morphology (Figure 4 ), while loss of rab3 causes an unmistakable change in active zone size and distribution within the presynaptic terminal (Graf et al., 2009 ). Second, we show that rab3-GAP mutant synapses have a slightly lower release probability at low extracellular calcium (Figure 5 ), while there is an increase in release probability at rab3 mutant NMJs (Graf et al., 2009 ). We therefore investigated synaptic homeostasis in a recently characterized rab3 mutant (rab3 rup ; Graf et al., 2009) . As shown in Figure 6 , the average mEPSP ( Figures 6A and 6D ) and EPSP amplitudes ( Figures 6A and 6E ) as well as quantal content (Figure 6F ) were similar to wild-type (p > 0.05) confirming that synaptic efficacy in response to single APs is normal in rab3 mutants (see Graf et al., 2009) . We then challenged the rab3 rup mutant with PhTX incubation, causing a significant decrease in mEPSP amplitude with respect to control (Figures 6B and 6D ; p < 0.001). In the rab3 rup mutant, following application of PhTX, we find a robust increase in quantal content ( Figure 6F ; p < 0.001) that restores EPSP amplitudes toward wild-type (Figure 6E ; p < 0.001). Although EPSP amplitudes remain significantly smaller than baseline, this difference is relatively small and there is a pronounced, significant increase in quantal content indicative of a clear homeostatic increase in presynaptic release ( Figure 6F ). We next assessed whether a prolonged homeostatic challenge imposed by a mutation in the GluRIIA subunit would affect synaptic homeostasis in the rab3 mutant. We therefore generated rab3 rup -GluRIIA SP16 double mutants and find a robust, homeostatic increase in transmitter release in the double mutant that is similar to the one seen in GluRIIA mutants alone (Figures 6C-6F ). This demonstrates that the sustained expression of synaptic homeostasis is unaffected in a rab3 mutant. We conclude that Rab3 is not required for the rapid induction or the sustained expression of synaptic homeostasis.
Rab3 Is the Effector GTPase for Rab3-GAP during Synaptic Homeostasis
The observation that synaptic homeostasis is normal in a rab3 mutant could mean that Rab3-GAP controls synaptic homeostasis via a small GTPase other than Rab3 (Tcherkezian and Lamarche-Vane, 2007) . To test this possibility, we generated double mutants of rab3-GAP and rab3 rup . The presence of the rab3-GAP transposon insertion in the double mutant was unambiguous based on the presence of the mini-white gene in the w À background of the rab3 rup mutation. A defect in synaptic homeostasis in the double mutant would indicate that Rab3-GAP does not function with Rab3 during homeostasis, while normal homeostasis would imply that Rab3 is the effector GTPase of Rab3-GAP. As shown in Figure 7 , PhTX incubation causes a significant decrease in mEPSP amplitude in rab3- rup double mutants (p < 0.001; Figure 7C ). We find a significant, nearly 2-fold, increase in quantal content following PhTX-treatment in rab3- rup double mutants ( Figure 7E) compared to controls (p < 0.001). Error bars represent SEM.
Furthermore, in genetic terms, these data are consistent with the interpretation that Rab3 functions, directly or indirectly, to oppose the induction or expression of synaptic homeostasis. The action of Rab3-GAP would then be to relieve Rab3-dependent opposition and allow homeostatic plasticity to proceed. We also examined synapse morphology in the rab3-GAPrab3 rup double mutants. The rab3-GAP mutant has no defect in synapse development (Figure 4 ), whereas the rab3 rup mutant shows a dramatic change in synapse organization and active zone size (Graf et al., 2009 ). In the double mutant, synapse morphology shows defects that are identical to that observed in rab3 rup alone (data not shown). Thus, all aspects of synapse morphology and physiology are epistatic to rab3 rup , but the data highlight different activities of Rab3 during synapse development and homeostasis. The data suggest that Rab3 is necessary for normal morphological synapse development (Graf et al., 2009) , whereas it opposes the expression of homeostatic plasticity (this study). Rab3-GAP converts the GTP-bound form of Rab3 to Rab3-GDP (Fukui et al., 1997) . One possibility, therefore, is that Rab3-GTP could accumulate presynaptically in the rab3-GAP mutant and thereby block homeostatic plasticity. If this is the case, then overexpression of a constitutively active rab3 (GTPase defective: UAS-YFP-rab3.Q80L CA ; Zhang et al., 2007) should block synaptic homeostasis. A similar constitutively active Rab3 CA (rab3A.Q81L) was shown to interact with Rab3-GAP in vitro (Clabecq et al., 2000) . We overexpressed the GTPase defective rab3 mutation (here referred to as UASrab3 CA ) in either a wild-type (not shown) or in the rab3 rup mutant background (Figure 8 ). In neither case did we observe a defect in synaptic homeostasis. We confirmed that UAS-rab3
CA is functional by demonstrating that this transgene is able to rescue the defects in active zone organization observed in the rab3 rup mutant ( Figure 8D ; Graf et al., 2009 ). Based on these data, several conclusions can be made. First, rab3-GAP mutations do not block synaptic homeostasis simply by causing an inappropriate accumulation of Rab3-GTP. Second, the hydrolysis of Rab3-GTP to Rab3-GDP is not required for synaptic homeostasis. This is consistent with the observation that rab3 mutations do not block synaptic homeostasis. We also attempted the converse experiment to overexpress a dominant negative rab3 transgene (UAS-YFP-rab3.T35N; Zhang et al., 2007) . However, we find that this transgene is not efficiently trafficked to the NMJ (see also Niwa et al., 2008) , which precludes us from testing the function of this mutant transgene at the NMJ. One plausible explanation for our data is that Rab3 does not directly oppose homeostatic plasticity. Rather, Rab3 could scaffold a homeostatic repressor that prevents homeostatic plasticity and Rab3-GAP competes with this repressor for Rab3 binding. If Rab3-GAP functions at or near the active zone, then the homeostatic repressor would be displaced by Rab3-GAP and vesicles at or near the synapse could participate in homeostatic plasticity. In the rab3-GAP mutant, the repression of synaptic homeostasis would persist and homeostasis would be blocked, as observed. Conversely, in the absence of Rab3, the repressor would never be scaffolded to the vesicle and synaptic homeostasis would proceed regardless of whether or not Rab3-GAP was present, as observed (Figure 9 ).
DISCUSSION
Here, we define a function for Rab3-GAP and Rab3 during synaptic homeostasis. We suggest that these molecules participate in a presynaptic signaling system that controls the expression of synaptic homeostasis. We also provide genetic evidence for a mechanism that can oppose the homeostatic modulation of presynaptic release probability. Rab3 and Rab3-GAP are well known signaling molecules that are thought to modulate a late stage in synaptic vesicle release (Wang et al., 1997 ; Schlü ter , 2004; Sakane et al., 2006) . These molecules have never before been implicated in the mechanisms of homeostatic plasticity.
An Emerging Model for Homeostatic Control of Presynaptic Release
The function of Rab3-GAP and Rab3 have been analyzed extensively, both biochemically and genetically, in systems ranging from yeast to the mammalian central nervous system (Fischer von Mollard et al., 1990; Fukui et al., 1997; Wang et al., 1997; Geppert and Sü dhof, 1998; Clabecq et al., 2000; Fukuda, 2008) . Rab3 associates with the synaptic vesicle only in a GTP-bound form (Fischer von Mollard et al., 1990) , and there are several ($10 on average) copies of Rab3-GTP on an individual synaptic vesicle (Takamori et al., 2006) . It was also shown that Rab3 binds to several presynaptic proteins, most often in its GTP-bound form (Wang et al., 1997; Kanno et al., 2010) . Rab3-GAP is required to promote hydrolysis of Rab3-GTP to Rab3-GDP (Fukui et al., 1997) . It is unknown precisely when and where Rab3-GAP acts upon Rab3-GTP, but evidence suggests that this interaction may occur at the synapse (Oishi et al., 1998) . For example, Rab3-GTP is on the vesicle (Takamori et al., 2006) and delivered to the synapse, where it is found bound to the active zone associated protein RIM (Wang et al., 1997) .
Biochemical data indicate that clathrin-coated vesicles lack Rab3-GTP (Fischer von Mollard et al., 1991) . In combination, these data place Rab3-GAP activity at or near the release site. The data presented here are consistent with a model in which Rab3-GTP acts, directly or indirectly, to inhibit the progression of synaptic homeostasis at a late stage of vesicle release, and that Rab3-GAP functions to inactivate this action of Rab3-GTP. We show that loss of Rab3-GAP blocks both the rapid induction and sustained expression of synaptic homeostasis. Rab3 mutations alone do not block synaptic homeostasis and synaptic homeostasis proceeds normally in the rab3-rab3-GAP double mutant. Genetically, these data indicate that the presence of Rab3 is required for the block of synaptic homeostasis observed in the rab3-GAP mutant. Thus, Rab3 is likely to be the cognate GTPase for Rab3-GAP. Furthermore, in genetic terms, Rab3 functions to oppose the progression of synaptic homeostasis and, when it is removed, homeostasis proceeds.
We considered the possibility that homeostasis proceeds in the absence of Rab3 because another, redundant Rab takes the place of Rab3. In yeast membrane trafficking, there is evidence for semiredundant Rab function (Grosshans et al., 2006) . However, this seems to be an exception because Rabs are hypothesized to have unique binding affinities for downstream effector proteins that are essential for their ability to define discrete membrane domains within membrane trafficking and secretory systems (Grosshans et al., 2006; Wickner and Schekman, 2008) . In C. elegans, Rab3 and Rab27 are both involved in synaptic vesicle release and they can be activated by a common exchange factor (Mahoney et al., 2006) . However, based upon available genetic data, these Rabs do not appear to function redundantly during release (Mahoney et al., 2006) . In Drosophila, loss of Rab3 causes a dramatic change in active zone size and organization (Graf et al., 2009 ). Thus, a redundant Rab would have to selectively and completely replace Rab3 function during synaptic homeostasis without rescuing synapse development, and this seems unlikely. Finally, since Rab3 is required for the complete block of synaptic homeostasis observed in the rab3-GAP mutant, we can conclude that Rab3 itself participates in mechanisms that determine whether or not synaptic homeostasis will proceed. Next, we considered the possibility that Rab3 accumulates in a GTP-bound form at the synapse in the rab3-GAP mutant background, and this accumulation could block homeostatic plasticity. This model is attractive because it could explain why loss of Rab3 does not block homeostatic plasticity. However, a direct test of this model failed to provide supporting evidence. We overexpressed a constitutively active rab3 transgene in the rab3 mutant background. This experiment should mimic the accumulation of Rab3-GTP in a rab3-GAP mutant background. We find that the constitutively active rab3 transgene (rab3 CA ) is trafficked to the NMJ and localizes in a manner that is indistinguishable from overexpressed wild-type Rab3 (not shown). Furthermore, rab3 CA has activity at the synapse because it rescues the defects in active zone organization that are caused by loss of rab3. In addition, constitutively active Rab3A was shown to biochemically interact with Rab3-GAP (Clabecq et al., 2000) . However, the expression of rab3 CA did not disrupt synaptic homeostasis.
Therefore, aberrant accumulation of Rab3-GTP is not the cause of impaired synaptic homeostasis in the rab3-GAP mutant and we are forced to consider another model. Another activity of Rab3-GAP that could be relevant to synaptic homeostasis is its ability to physically bind Rab3-GTP (Clabecq et al., 2000) . We know that Rab3-GTP can bind several synaptic proteins including RIM and Rabphillin (Kanno et al., 2010) . Moreover, we provide evidence that Rab3's GTPase activity is not limiting during synaptic homeostasis (Figure 8 ). Therefore, we propose that Rab3-GAP competes for Rab3-GTP binding with another protein. If this other protein inhibits synaptic homeostasis when bound to the synaptic vesicle, then displacement by Rab3-GAP binding would be a required step for synaptic homeostasis to proceed. This model can explain all of our experimental data ( Figure 9 ). First, Rab3-GAP would be necessary for synaptic homeostasis. Second, synaptic homeostasis would proceed normally in the rab3 mutant because the homeostatic inhibitor would no longer localize to the synaptic vesicle. Third, overexpression of rab3 CA in the rab3 mutant background would not block synaptic homeostasis because Rab3-GAP would still be able to compete for Rab3-GTP binding, displace the homeostatic inhibitor, and allow homeostatic plasticity to proceed.
This model is consistent with a conserved function of Rab proteins throughout the membrane trafficking and secretory pathways of organisms ranging from yeast to mammals. Rab proteins, in their GTP-bound state, function to nucleate the assembly of ''effector'' protein complexes that define membrane microdomains (Grosshans et al., 2006; Wickner and Schekman, 2008) . However, throughout the literature, more is known about the assembly of these Rab-dependent complexes than is known about their disassembly (Nottingham and Pfeffer, 2009) . Our model assumes that the binding of Rab3-GAP to Rab3 and the Rab3 CA mutant protein is sufficient to disrupt effector binding (including the proposed homeostatic inhibitor). It is generally believed that Rab-GAPs interact with their cognate GTPases with lower affinity than the effector proteins. However, although Rab3-GAP has a relatively low affinity for Rab3A, Rab3-GAP effectively competes with an effector (Rabphillin) for binding to Rab3A and this is true even when Rab3A harbors the Q81L mutation (Clabecq et al., 2000) . These data support the possibility that Rab3-GAP could compete for effector binding and disrupt a Rab3-GTP dependent scaffold. This is not the only manner in which Rab3-GAP differs from other Rab-GAPs. Rab3-GAP is somewhat unique in that it does not contain additional protein-protein interaction motifs. Thus, unlike IQ-GAP proteins for instance, it seems unlikely that Rab3-GAP has
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Our genetic data support the conclusion that Rab3-GAP is required for synaptic homeostasis. We propose that homeostasis cannot proceed if Rab3-GTP is bound to an unidentified homeostatic repressor (red) at or near the active zone. Binding of Rab3-GAP (green) to Rab3-GTP displaces the homeostatic repressor and allows synaptic homeostasis to proceed (top). In the rab3-GAP mutation (lower left) the homeostatic repressor remains bound to Rab3-GTP and prevents an additional step necessary for homeostatic plasticity. Based on a decreased release probability observed at low extracellular calcium in the rab3-GAP mutant, we speculate that the repressor might prevent close association of docked vesicles with the presynaptic calcium channel. In the rab3 mutant (lower right) the repressor fails to bind to the vesicle and homeostasis proceeds.
unique functions that are independent of Rab3, consistent with our double-mutant analysis of rab3 and rab3-GAP. Finally, we have considered the possibility that the rab3-GAP mutation could create a ceiling effect where baseline transmission is normal but release cannot be potentiated under any condition. Several pieces of data argue against this possibility. First, by elevating extracellular calcium, quantal content can be increased in the rab3-GAP mutant, indicating that there is no restriction on the absolute number of quanta that can be released. Second, during a stimulus train (20 Hz, 0.4 mM extracellular calcium), the rab3-GAP mutant plateaus at a higher EPSP amplitude compared to wild-type ( Figures 5A-5C ). Again, there is no evidence for a ceiling effect in rab3-GAP. Finally, we have previously demonstrated that mutations that cause a severe defect in baseline transmission can still undergo homeostatic compensation (Dickman and Davis, 2009) . Taken together, these data argue against a simple ceiling effect and support the conclusion that Rab3-GAP is directly involved in the mechanisms of synaptic homeostasis.
A question that we are not yet able to address is which step in our model is modified during the induction of synaptic homeostasis. One interesting possibility is that the interaction of Rab3-GTP with the homeostatic repressor is regulated. For example, if this interaction is stabilized, then homeostatic plasticity would be opposed and, conversely, if the interaction is weakened, then homeostasis would be allowed to proceed. A recent study in C. elegans (Simon et al., 2008) provided evidence that an unknown retrograde signal, from muscle to motoneuron, causes increased expression of YFP-Rab3 at the presynaptic terminal. Although we do not find evidence for a similar phenomenon at the Drosophila NMJ during synaptic homeostasis, these data support the possibility that the Rab3/ Rab3-GAP signaling complex could be a downstream, regulated target of a homeostatic, retrograde signal at the NMJ.
Additional Considerations
Interpreting our data requires consideration of a recent study examining the effects of a rab3 mutation on synapse organization at the Drosophila NMJ (Graf et al., 2009) . In this study, it was discovered that a rab3 mutation caused a dramatic accumulation of both the active zone-associated protein Bruchpilot (Brp, T-bars, the Drosophila homolog of CAST/ELKS; Kittel et al., 2006) and presynaptic calcium channels at a subset of active zones (Graf et al., 2009) . Based on these and other data it was suggested that Rab3 promotes the nucleation of new active zones, and without this activity, active zones coalesce (Graf et al., 2009) . We are able to clearly dissociate any morphological reorganization of the NMJ from a blockade of synaptic homeostasis. The rab3 mutants have altered NMJ morphology, but normal synaptic homeostasis (Figure 6 ), whereas rab3-GAP mutants have normal NMJ morphology and a defect in synaptic homeostasis (Figures 2 and 4) .
It is also important to consider why rab3 mutants do not show excessive homeostatic compensation. We predict that Rab3 and Rab3-GAP will not control the magnitude of the homeostatic response, just whether or not it is allowed to proceed. Additional negative feedback signaling mechanisms would be responsible for determining the magnitude of the homeostatic response.
This would explain why we do not observe excessive homeostatic compensation in the absence of Rab3. Thus, Rab3 and Rab3-GAP provide an additional layer of control on synaptic homeostasis, ensuring that modulation of release probability only occurs when, and perhaps where, appropriate.
Potential Mechanisms Underlying the Homeostatic Modulation of Vesicle Release Probability Ultimately, we would like to understand how presynaptic vesicle release is modulated during homeostatic plasticity. We know from previously published data that a homeostatic increase in vesicle release is due to a change in presynaptic release probability without a change in active zone number (Frank et al., 2006; Frank et al., 2009; Dickman and Davis, 2009 ). Mechanistically, the full functionality of presynaptic calcium channels is necessary for synaptic homeostasis (Frank et al., 2006 (Frank et al., , 2009 . However, it remains unknown whether synaptic homeostasis involves a change in calcium channel number versus calcium channel function. Given these prior data, one possibility is that the homeostatic signaling system, identified here, acts upon presynaptic calcium channels to prevent a change in calcium influx. In this respect, the involvement of RIM and RIM binding protein are intriguing since RIM binds to Rab3-GTP and has been proposed to influence calcium-channel function (Kiyonaka et al., 2007; Hibino et al., 2002) .
Rab3-GAP is the first protein to be implicated in the homeostatic modulation of presynaptic release that directly interacts with a resident synaptic vesicle protein. This fact, and our analysis of baseline synaptic transmission in the rab3-GAP mutant raise the possibility that the homeostatic modulation of presynaptic release also includes mechanisms that are independent of increased calcium influx. For example, we observe a defect in presynaptic release probability in the rab3-GAP mutant that occurs only when we record in low extracellular calcium. This defect could reveal a function of Rab3-GAP during vesicle release, or it could reflect the activity of the proposed homeostatic repressor on baseline synaptic transmission. One possibility that could explain the decrease in release probability is that synaptic vesicles reside at a greater physical distance from the calcium channel in the rab3-GAP mutant. When recording in low extracellular calcium, the calcium microdomains at the active zone would not effectively trigger the release of these more distant vesicles. This model would suggest that enhanced coupling of the synaptic vesicle and the calcium channel is part of the homeostatic modulation of presynaptic release. By extension, the action of the homeostatic repressor would be to prevent a tight association of the synaptic vesicle with the calcium channel. It is interesting to speculate that the homeostatic repressor could be Rabphillin. It has been shown that Rabphillin can compete with Rab3-GAP for binding to Rab3-GTP (Clabecq et al., 2000) . Rabphillin has two C2 domains that could confer calcium-dependence to this protein-protein interaction and, by extension, homeostatic plasticity (Geppert and Sü dhof, 1998) . Ultimately, we cannot rule out a molecular change that influences the functionality of the calcium sensor for vesicle fusion. Regardless, our data identify a homeostatic mechanism that functions at a late stage of vesicle release to modulate presynaptic release probability.
Rab3-GAP and Dysbindin Mutations Have Similar Effects on Synaptic Transmission and Synaptic Homeostasis
In combination with a previously published genetic screen (Dickman and Davis, 2009) we have now identified 13 mutations that disrupt the expression of synaptic homeostasis without severely altering baseline synaptic transmission. Among these genes are rab3-GAP and dysbindin (Dickman and Davis, 2009 ). The mutant phenotypes for rab3-GAP and dysbindin are remarkably similar. In both cases, loss of function mutations have little effect on baseline transmission under standard recording conditions (0.4 mM extracellular calcium). However, decreasing extracellular calcium reveals a significant decrease in release probability. In agreement, we also observe an increase in short-term synaptic facilitation in both mutations. Furthermore, neither mutation has an effect on synapse morphology or active zone number. In dysbindin mutants, these effects were shown to be downstream or independent of presynaptic calcium influx. It is tempting to place Dysbindin into the proposed model for homeostatic plasticity (Figure 9 ). One possibility is that Dysbindin functions to stabilize the close association of synaptic vesicles with the presynaptic calcium channel. The absence of Dysbindin would therefore phenocopy the rab3-GAP mutant but function through a different set of molecular interactions on the synaptic vesicle. The similarity between the phenotypes of dysbindin and rab3-GAP are also interesting because dysbindin has been linked to schizophrenia in human (Ross et al., 2006) . The intriguing possibility that Dysbindin interacts with Rab3-Rab3-GAP signaling will be the subject of future studies.
EXPERIMENTAL PROCEDURES Electrophysiology
Sharp-electrode recordings were made from muscle 6 in abdominal segment 2 and 3 of third instar larvae using an Axopatch 200B amplifier (Axon Instruments), as previously described (Frank et al., 2006 (Frank et al., , 2009 . The extracellular HL3 saline contained (in mM): 70 NaCl, 5 KCl, 10 MgCl 2 , 10 NaHCO 3 , 115 sucrose, 4.2 trehalose, 5 HEPES, and 0.4 (unless specified) CaCl 2 . For acute pharmacological homeostatic challenge, larvae were incubated in Philanthotoxin-433 (PhTX; 10, or 20 mM; Sigma-Aldrich) for 10 min (Frank et al., 2006) . See Supplemental Experimental Procedures for additional detail.
Immunocytochemistry
Larvae were fixed and analyzed as described previously (Frank et al., 2009 ). The following primary antibodies were used at the indicated dilutions: antiBrp (1:100; nc82; Wagh et al., 2006) ; anti-Dlg (1:5,000), anti-synaptotagmin (1:500), anti-Rab3 (1:1000; Graf et al., 2009), and anti-GFP (1:200) . See Supplemental Experimental Procedures for additional detail.
Generation of UAS-CFP-Rab3-GAP
The UAS-CFP-Rab3-GAP construct was generated by first amplifying the fulllength rab3-GAP open reading frame of isoform A from the BDGP DGC cDNA clone LD40982 and cloning into pENTR/D-TOPO (Invitrogen). The rab3-GAP cDNA was then directly cloned into the UAS-N-terminal Venus (EYFP) vector, pTCW (T. Murphy, Drosophila Genomics Resource Center) using the Gateway recombination cloning system (Invitrogen). The following primers were used to amplify the rab3-GAP open reading frame: caccATGGCTTGCGAAGTAAAACAC and CTAATTCTGCAGGATACGCA. The construct was confirmed by sequencing. Transgenic flies were generated by standard injection methods by BestGene Inc.
Quantitative RT-PCR Primer-probes were designed and developed by Applied Biosystems (see Supplemental Experimental Procedures for additional detail). 
Fly Stocks and Genetics
Data Analysis
Evoked EPSPs were analyzed using custom-written routines in Igor Pro 5.0 (Wavemetrics), and spontaneous mEPSPs were analyzed using Mini Analysis 6.0.0.7 (Synaptosoft).
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